We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

2,215 hedge funds and large institutions have $137B invested in Gilead Sciences in 2025 Q4 according to their latest regulatory filings, with 334 funds opening new positions, 879 increasing their positions, 736 reducing their positions, and 109 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more first-time investments, than exits

New positions opened: 334 | Existing positions closed: 109

47% more funds holding in top 10

Funds holding in top 10: 19 → 28 (+9)

19% more repeat investments, than reductions

Existing positions increased: 879 | Existing positions reduced: 736

17% more capital invested

Capital invested by funds: $117B → $137B (+$20B)

9% more funds holding

Funds holding: 2,026 → 2,215 (+189)

5.13% more ownership

Funds ownership: 85.16% → 90.29% (+5.1%)

8% more call options, than puts

Call options by funds: $916M | Put options by funds: $852M

Holders
2,215
Holders Change
+189
Holders Change %
+9.33%
% of All Funds
26.94%
Holding in Top 10
28
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+47.37%
% of All Funds
0.34%
New
334
Increased
879
Reduced
736
Closed
109
Calls
$916M
Puts
$852M
Net Calls
+$64.5M
Net Calls Change
-$83.2M

Top Buyers

1
Invesco
Invesco
Georgia
+$3.44B
2
BlackRock
BlackRock
New York
+$840M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$640M
4
Boston Partners
Boston Partners
Massachusetts
+$513M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$500M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.18B
2
Capital Research Global Investors
Capital Research Global Investors
California
-$572M
3
Dodge & Cox
Dodge & Cox
California
-$468M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$392M
5
Deutsche Bank
Deutsche Bank
Germany
-$336M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIM
1201
Contravisory Investment Management
Massachusetts
$704K -$23.2K -191 -3%
WP
1202
Waycross Partners
Kentucky
$704K – – –
FFG
1203
Fortem Financial Group
California
$703K -$36.8K -303 -5%
CA
1204
Continuum Advisory
Idaho
$701K +$69.6K +573 +11%
MG
1205
Marex Group
$701K +$91.8K +755 +15%
AO
1206
Advisor OS
Illinois
$699K +$55.1K +453 +9%
VIA
1207
Virtus Investment Advisers
Connecticut
$697K +$208K +1,709 +43%
MSFP
1208
Mark Sheptoff Financial Planning
Connecticut
$694K +$687K +5,651 New
MBT
1209
Montecito Bank & Trust
California
$683K -$1.7K -14 -0.3%
USWIA
1210
UP Strategic Wealth Investment Advisors
Pennsylvania
$680K – – –
CNBT
1211
Canandaigua National Bank & Trust
New York
$677K -$17.3K -142 -3%
WF
1212
WinCap Financial
Massachusetts
$676K +$12K +99 +2%
MC
1213
Mathes Company
New York
$675K – – –
VCAM
1214
Van Cleef Asset Management
Ohio
$674K – – –
A
1215
Allianz
Germany
$671K +$612K +5,040 +1,172%
NFTC
1216
North Forty Two & Co
Oregon
$663K – – –
RIL
1217
Rothschild Investment LLC
Illinois
$660K -$851 -7 -0.1%
MYIA
1218
Mount Yale Investment Advisors
Colorado
$659K +$382K +3,141 +141%
VWA
1219
VERITY Wealth Advisors
United States
$655K – – –
SG
1220
Sharper & Granite
California
$654K -$29.2K -240 -4%
CHJWM
1221
Carlton Hofferkamp & Jenks Wealth Management
Texas
$652K -$4.25K -35 -0.7%
CF
1222
Centaurus Financial
California
$650K -$206K -1,697 -24%
FFL
1223
Future Fund LLC
Illinois
$647K -$86.8K -714 -12%
KW
1224
Keyvantage Wealth
Pennsylvania
$647K -$5.96K -49 -0.9%
Kovitz Investment Group Partners
1225
Kovitz Investment Group Partners
Illinois
$647K -$13.8M -113,758 -96%
47 48
49
50 51

GILD Hedge Fund Activity: Q4 2025 in Review

2,215 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2025, worth a combined $137B — up 17% from $117B a quarter earlier.

Buyers outnumbered sellers: 334 funds opened new GILD positions and 109 closed out — a net gain of 225 holders — while 879 added to existing stakes and 736 trimmed.

The largest buyer was Invesco, adding an estimated $3.44B. The largest seller was Wellington Management Group, cutting an estimated $1.18B.

  • 2,215 institutional investors held Gilead Sciences (GILD) as of Q4 2025, up from 2,026 in Q3 2025.
  • Funds reported $137B of Gilead Sciences stock for Q4 2025, up 17% quarter-over-quarter.
  • 334 funds opened new Gilead Sciences positions in Q4 2025 and 109 closed out, a net change of +225 holders.
  • The largest Gilead Sciences buyer in Q4 2025 was Invesco, an estimated $3.44B added.
  • The largest Gilead Sciences seller in Q4 2025 was Wellington Management Group, an estimated $1.18B sold.

Based on aggregated 13F filings for Q4 2025.